Solid Biosciences $75 million common stock PIPE offering
The financing is taking place concurrently with the company’s acquisition of AavantiBio
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
EDAP TMS $23 million follow-on offering
The ADSs are listed on the Nasdaq Global Market
InnoCare Pharma RMB2.9 billion Shanghai IPO
This is the largest A-share listing by an overseas-listed biotechnology company in 2022 so far
Allakos $150 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Medtronic Global Holdings €3.5 billion notes offering
The investment-grade notes were issued in four tranches
Alignment Healthcare $132.75 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
IDEAYA Biosciences $92 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Alnylam Pharmaceuticals $1.035 billion convertible senior notes offering
The 1% convertible notes are due 2027
Immunocore $250 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market